News

MRI, gadolinium, contrast agents, Wolters Kluwer, safety issue

New results in animals highlight a major safety concern regarding a class of magnetic resonance imaging (MRI) contrast agents used in millions of patients annually, according to a new paper. The...

Bracco, Lumason, first U.S. echocardiography procedure, Morristown

Bracco Imaging announced that the first echocardiography imaging procedure with Lumason was performed in May at Morristown Medical Center, part of the Atlantic Health System, in New Jersey....

Visipaque, IOCM, LOCM, angioplasty, EuroPCR 2015

Significantly fewer renal and cardiac events are associated with angioplasty procedures using isosmolar contrast medium (IOCM) agent Visipaque (iodixanol) than those using low-osmolar contrast...

gadolinium, brain, contrast MRI, Radiology, Kanal

New research, published in the journal Radiology, suggests some types of a popular contrast agent used in magnetic resonance imaging (MRI) exams may remain in the brain for years, but...

Bracco Imaging, through its business unit Bracco Injeneering SA, announced the availability of its EmpowerCTA+, an advanced engineering contrast injection system.

nanoparticles, stroke, tPA, blood clot, magnetic, MRI, antiplatelet

By loading magnetic nanoparticles with drugs and dressing them in biochemical camouflage, Houston Methodist researchers say they can destroy blood clots 100 to 1,000 times faster than a commonly...

Bayer HealthCare’s Mark 7 Arterion angiographic contrast injector

There have been several recent advances with contrast media injector technology, including cutting costs by reducing contrast waste and automated data collection for the dose a patient receives....

Nephrocheck Test System, Blood testing, contrast media

Ortho-Clinical Diagnostics Inc. announced the nationwide availability to hospitals of the Nephrocheck Test System designed to help healthcare providers identify patients at risk of developing...

Bayer Healthcare, Gadavist, FDA, approval, pediatric patients, contrast media

Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use with magnetic resonance imaging (MRI) in pediatric patients...

Bayer unveiled version 2.5 of its Radimetrics Enterprise Platform at the 2014 Radiological Society of North America (RSNA) Scientific Assembly and Annual Meeting. The enhanced version has new...

Data from a Bayer study in children less than 2 years of age (infants) was presented at the 2014 Radiological Society of North America (RSNA) scientific assembly and annual meeting....

Bracco Diagnostics Inc. announced the availability of its Isovue (iopamidol injection) Imaging Bulk Package (IBP), a specific combination multi-patient, multi-dose compliant contrast medium...

The U.S. Food and Drug Administration (FDA) approved Lumason (sulfur hexafluoride lipid microsphere) for patients whose ultrasound image of the heart (echocardiograms) are hard to see with...

blood testing, nephrocheck

The U.S. Food and Drug Administration has allowed marketing of the NephroCheck test, a first-of-a-kind laboratory test to help determine if certain critically ill hospitalized patients are at risk...

Mallinckrodt U.S. Launch OptiSync Contrast Data Management System

Mallinckrodt announced the U.S. launch of the OptiSync data management system as a new technology in its Global Medical Imaging segment. 

September 10, 2014 — According to new research performed at the Mayo Clinic, iodine-based contrast material injected intravenously to enhance computed tomography (CT) images can be safely used in...

Imaging experts from the American Society of Echocardiography (ASE) released a paper, "Guidelines for the Cardiac Sonographer in the Performance of Contrast Echocardiography: A Focused Update from...

The American Society of Echocardiography Foundation (ASEF) launched the second version of its free mobile Echo AUC app at the ASE Silver Anniversary Scientific Sessions in Portland, Ore., last...

Iodixanol Iopamidol Contrast Media Peripheral Arteriography ACC.14 Clinical Stud

GE Healthcare announced results from a new clinical study, which showed that patients receiving iodixanol (Visipaque) 320mg I/ml reported less discomfort, characterized by heat or cold sensation...

Manhattan Scientifics announced a collaboration with Azano Biotech that will make NanoMRX Precision Nanoparticles available for purchase.